153 related articles for article (PubMed ID: 29995047)
1. Redox-responsive cisplatin nanogels for anticancer drug delivery.
Zhang W; Tung CH
Chem Commun (Camb); 2018 Jul; 54(60):8367-8370. PubMed ID: 29995047
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
3. Redox-responsive hyaluronic acid nanogels for hyperthermia- assisted chemotherapy to overcome multidrug resistance.
Li B; Xu Q; Li X; Zhang P; Zhao X; Wang Y
Carbohydr Polym; 2019 Jan; 203():378-385. PubMed ID: 30318226
[TBL] [Abstract][Full Text] [Related]
4. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
5. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
Chen W; Achazi K; Schade B; Haag R
J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
[TBL] [Abstract][Full Text] [Related]
6. Triggered doxorubicin release using redox-sensitive hyaluronic acid-g-stearic acid micelles for targeted cancer therapy.
Jeong GW; Jeong YI; Nah JW
Carbohydr Polym; 2019 Apr; 209():161-171. PubMed ID: 30732795
[TBL] [Abstract][Full Text] [Related]
7. Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery.
Lou S; Gao S; Wang W; Zhang M; Zhang J; Wang C; Li C; Kong D; Zhao Q
Nanoscale; 2015 Feb; 7(7):3137-46. PubMed ID: 25613320
[TBL] [Abstract][Full Text] [Related]
8. Redox-responsive degradable prodrug nanogels for intracellular drug delivery by crosslinking of amine-functionalized poly(N-vinylpyrrolidone) copolymers.
Peng H; Huang X; Melle A; Karperien M; Pich A
J Colloid Interface Sci; 2019 Mar; 540():612-622. PubMed ID: 30690386
[TBL] [Abstract][Full Text] [Related]
9. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
10. Hydrophilicity/Hydrophobicity reversable and redox-sensitive nanogels for anticancer drug delivery.
Yang H; Wang Q; Chen W; Zhao Y; Yong T; Gan L; Xu H; Yang X
Mol Pharm; 2015 May; 12(5):1636-47. PubMed ID: 25833093
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Characterization of Dual-Sensitive Fluorescent Nanogels for Enhancing Drug Delivery and Tracking Intracellular Drug Delivery.
Wu SY; Debele TA; Kao YC; Tsai HC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534813
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
13. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted and nitric oxide-generated nanogels of keratin and hyaluronan for enhanced cancer therapy.
Sun Z; Yi Z; Cui X; Chen X; Su W; Ren X; Li X
Nanoscale; 2018 Jul; 10(25):12109-12122. PubMed ID: 29915821
[TBL] [Abstract][Full Text] [Related]
15. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
16. Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels.
Zhang W; Zhang Z; Tung CH
Chem Commun (Camb); 2017 Jan; 53(4):779-782. PubMed ID: 27999837
[TBL] [Abstract][Full Text] [Related]
17. Bio-derived poly(gamma-glutamic acid) nanogels as controlled anticancer drug delivery carriers.
Bae HH; Cho MY; Hong JH; Poo H; Sung MH; Lim YT
J Microbiol Biotechnol; 2012 Dec; 22(12):1782-9. PubMed ID: 23221543
[TBL] [Abstract][Full Text] [Related]
18. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
19. Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.
Daga M; de Graaf IAM; Argenziano M; Barranco ASM; Loeck M; Al-Adwi Y; Cucci MA; Caldera F; Trotta F; Barrera G; Casini A; Cavalli R; Pizzimenti S
Toxicol In Vitro; 2020 Jun; 65():104800. PubMed ID: 32084521
[TBL] [Abstract][Full Text] [Related]
20. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
